# Analysis and prediction of serological indicators associated with colorectal interval polyposis after resection

**Authors:** Yuan Lan, Li Zhang, Ren Jun Li

PMC · DOI: 10.3389/fendo.2025.1634468 · Frontiers in Endocrinology · 2025-07-30

## TL;DR

This study identifies risk factors for the recurrence of colorectal polyps after surgery, helping to guide early detection and monitoring.

## Contribution

The study develops a predictive model for interval polyposis using serological and clinical factors.

## Key findings

- Hypertension, diabetes, and high triglyceride levels are significant predictors of interval polyposis.
- Patients with more initial polyps are at higher risk for recurrence.
- Regular monitoring is recommended for high-risk individuals to detect polyps early.

## Abstract

The examination of the endoscope and the subsequent rediscovery of polyps after endoscopic intervention presents a significant clinical challenge. Multiple factors may contribute to this phenomenon. This study aimed to identify determinants of interval polyposis by analyzing common serological markers and polyp-related variables, ultimately developing a predictive model.

This retrospective study included 415 patients diagnosed with colorectal polyps who underwent either endoscopic mucosal resection (EMR) or endoscopic submucosal dissection (ESD) at Chaohu Hospital affiliated with Anhui Medical University between December 1, 2022 and December 31, 2023. The primary objective was to evaluate associations between hematologic indicators, polyp-related characteristics, and the risk of rediscovery colorectal polyps. Interval polyposis was defined as the detection of one or more polyps within 18 months after the initial polypectomy, regardless of anatomical location. Follow-up data were obtained through electronic medical records, including demographic information (age, sex, smoking and alcohol use, hypertension, and diabetes history), anthropometric measures (weight, height, BMI), surgical details, polyp features (location, size, number, histological type), and relevant serological parameters.

Significant differences were observed between the non-interval polyposis and interval polyposis groups in terms of hypertension, diabetes, triglycerides (TG) and the number of polyps (P < 0.05). Binary logistic regression analysis identified four independent risk factors: hypertension (OR, 2.741; 95% CI, 1.451-5.179), diabetes (OR, 4.828; 95% CI, 1.943-11.995), number of polyps (OR, 1.211; 95% CI, 1.078-1.361) and triglyceride levels (OR, 1.823; 95% CI, 1.303-2.551).

Hypertension, diabetes, an increased number of polyps and elevated triglyceride levels are independent predictors of colorectal interval polyposis following endoscopic resection. These findings underscore the importance of monitoring blood pressure, blood sugar, triglyceride levels and conducting regular colonoscopic surveillance in high-risk individuals to facilitate early detection and management of interval polyposis.

## Linked entities

- **Diseases:** diabetes (MONDO:0005015)

## Full-text entities

- **Genes:** MUC1 (mucin 1, cell surface associated) [NCBI Gene 4582] {aka ADMCKD, ADMCKD1, ADTKD2, CA 15-3, CD227, Ca15-3}, CEACAM3 (CEA cell adhesion molecule 3) [NCBI Gene 1084] {aka CD66D, CEA, CGM1, CGM1a, W264, W282}, ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}, SLC17A5 (solute carrier family 17 member 5) [NCBI Gene 26503] {aka AST, ISSD, NSD, SD, SIALIN, SIASD}, AFP (alpha fetoprotein) [NCBI Gene 174] {aka AFPD, FETA, HPAFP}, MUC16 (mucin 16, cell surface associated) [NCBI Gene 94025] {aka CA125}, GGTLC5P (gamma-glutamyltransferase light chain 5 pseudogene) [NCBI Gene 653590] {aka GGT}
- **Diseases:** carcinoids (MESH:D002276), Hypertension (MESH:D006973), hamartomas (MESH:D006222), inflammatory (MESH:D007249), lipomas (MESH:D008067), familial adenomatous polyposis (MESH:D011125), TG (MESH:C566031), intestinal polyps (MESH:D007417), intraepithelial neoplasia or cancer (MESH:D002578), inflammatory bowel disease (MESH:D015212), interval (OMIM:610141), adenomatous polyps (MESH:D018256), hyperplastic (MESH:D000082242), cardiovascular complications (MESH:D002318), Interval polyposis (MESH:D044483), Colorectal polyp (MESH:D003111), colorectal cancer (MESH:D015179), Polyp (MESH:D011127), malignancy (MESH:D009369), diabetes (MESH:D003920), cardiac or pulmonary dysfunction (MESH:D006331)
- **Chemicals:** bilirubin (MESH:D001663), Hcy (MESH:D006710), glucose (MESH:D005947), UA (MESH:D014527), TG (MESH:D014280), polyethylene glycol (MESH:D011092), DBil (-), alcohol (MESH:D000438), lipid (MESH:D008055), blood glucose (MESH:D001786), cholesterol (MESH:D002784)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12343215/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12343215/full.md

## References

14 references — full list in the complete paper: https://tomesphere.com/paper/PMC12343215/full.md

---
Source: https://tomesphere.com/paper/PMC12343215